Dov Elefant

Insider Reports History

Location
Englewood Cliffs, NJ
Signature
/s/ Kathy Lee-Sepsick, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dov Elefant:

Company Role Class Num Shares Value Price $ Report Date Ownership
FEMASYS INC Chief Financial Officer Common Stock 58,436 $21,036 $0.3600 27 Aug 2025 Direct
Cellectar Biosciences, Inc. Chief Financial Officer Stock option (right to buy) 422,000 25 Jan 2022 Direct
FEMASYS INC Chief Financial Officer Stock Option (Right to Buy) 114,300 28 Jan 2025 Direct
FEMASYS INC Chief Financial Officer Common Warrants (right to buy) 38,828 27 Aug 2025 Direct
FEMASYS INC Chief Financial Officer Series A-1 Warrants 34,122 07 Nov 2025 Direct
FEMASYS INC Chief Financial Officer Series B-1 Warrants 34,122 07 Nov 2025 Direct
FEMASYS INC Chief Financial Officer Series C-1 Warrants 34,122 07 Nov 2025 Direct
FEMASYS INC Chief Financial Officer Senior Secured Convertible Notes $25,000 07 Nov 2025 Direct

Insider Reports Filed by Dov Elefant

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FEMY FEMASYS INC 07 Nov 2025 4 +$25,000 4 Chief Financial Officer 12 Nov 2025, 17:23
FEMY FEMASYS INC 27 Aug 2025 2 $0 4 Chief Financial Officer 28 Aug 2025, 16:37
FEMY FEMASYS INC 02 Jun 2025 1 +$20,000 4 Chief Financial Officer 04 Jun 2025, 15:51
FEMY FEMASYS INC 28 Jan 2025 2 $0 4 Chief Financial Officer 30 Jan 2025, 19:33
FEMY FEMASYS INC 01 Feb 2024 1 $0 4 Chief Financial Officer 02 Feb 2024, 16:43
FEMY FEMASYS INC 03 Jul 2023 2 $0 4 Chief Financial Officer 03 Jul 2023, 18:00
FEMY FEMASYS INC 28 Feb 2022 1 $0 4 Chief Financial Officer 01 Mar 2022, 15:38
FEMY FEMASYS INC 28 Feb 2022 0 $0 3 Chief Financial Officer 01 Mar 2022, 15:29
CLRB Cellectar Biosciences, Inc. 25 Jan 2022 1 $0 4 Chief Financial Officer 27 Jan 2022, 15:06